Skip to content
10-K

Annual Report

LISATA THERAPEUTICS, INC. LSTA

0000320017-26-000023

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 12, 2026 9.03M sh
Shares Diluted FY 2024 · Dec 31, 2025 8.69M sh
Shares Diluted FY 2024 · Dec 31, 2024 8.33M sh
Capex FY 2024 · Dec 31, 2025 $28K
Capex FY 2024 · Dec 31, 2024 $0
Operating Cash Flow FY 2024 · Dec 31, 2025 −$15.95M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$19.36M
Cash And Equivalents FY 2024 · Dec 31, 2025 $15.96M
Cash And Equivalents FY 2024 · Dec 31, 2024 $16.21M
Stockholders Equity FY 2024 · Dec 31, 2025 $14.86M
Stockholders Equity FY 2024 · Dec 31, 2024 $29.57M
Current Liabilities FY 2024 · Dec 31, 2025 $3.07M
Current Liabilities FY 2024 · Dec 31, 2024 $5.61M
Total Liabilities FY 2024 · Dec 31, 2025 $3.14M
Total Liabilities FY 2024 · Dec 31, 2024 $5.69M
Current Assets FY 2024 · Dec 31, 2025 $17.7M
Current Assets FY 2024 · Dec 31, 2024 $34.58M
Total Assets FY 2024 · Dec 31, 2025 $17.74M
Total Assets FY 2024 · Dec 31, 2024 $35M
Eps Diluted FY 2024 · Dec 31, 2025 −$1.91
Eps Diluted FY 2024 · Dec 31, 2024 −$2.40
Eps Basic FY 2024 · Dec 31, 2025 −$1.91
Eps Basic FY 2024 · Dec 31, 2024 −$2.40
Net Income FY 2024 · Dec 31, 2025 −$16.59M
Net Income FY 2024 · Dec 31, 2024 −$19.99M
Operating Income FY 2024 · Dec 31, 2025 −$18.21M
Operating Income FY 2024 · Dec 31, 2024 −$22.41M
Revenue FY 2024 · Dec 31, 2025 $170K
Revenue FY 2024 · Dec 31, 2024 $1M